SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as the community debates whether the stock is primed for a massive short squeeze, citing high short interest and a tight float ahead of potential upcoming catalysts. Investors are divided between bullish sentiment, which focuses on strong revenue growth and institutional buying, and deep skepticism toward management regarding communication and potential dilution.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is currently facing intense community debate as holders struggle with stagnant price action and project skepticism, while some investors view the current low valuation as a prime accumulation zone for long-term cycles. While critics label the project a stalled venture, others maintain conviction in the underlying ecosystem development, focusing on the potential for future utility and market recovery.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as institutional investors and the community weigh its transformation into an AI-compute and infrastructure powerhouse following the Northern Data acquisition. Shareholders are actively discussing a significant potential short squeeze, citing record-high short interest and management's ambitious revenue guidance tied to their expanding 250MW data center pipeline.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Accenture is currently under heavy selling pressure as investors grapple with fears that generative AI will disrupt the traditional consulting business model and lead to reduced demand for billable hours. While community sentiment is deeply polarized between those fearing structural decline and others aggressively bottom-fishing based on strong fundamentals and share buybacks, the stock remains a focal point for debates regarding the long-term impact of AI on professional services.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is seeing intense community focus as investors prepare for high-stakes clinical data readouts expected in the coming weeks, particularly regarding their obesity-pipeline maintenance study. Sentiment remains polarized between long-term holders betting on the drug's best-in-class potential and active traders navigating short-term volatility fueled by financing updates and institutional positioning.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing intense community debate following a significant price correction from its recent highs, with investors weighing the company's long-term potential in aerospace and defense against current volatility. While some focus on the upcoming inclusion in the Russell 2000 index as a potential catalyst, others remain skeptical about the firm's fundamentals and the impact of ongoing patent litigation.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as retail investors rally behind a multi-pronged legal strategy that recently secured a major commercial settlement with Samsung, fueling expectations for further settlements with industry giants like Micron and Google. The community is actively discussing the potential for a short squeeze due to significant short interest and upcoming patent-related court dates, with many long-term shareholders refusing to sell as they target significantly higher valuations.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is experiencing heightened market activity following a broader sector-wide recovery and increased investor focus on its expanding AI data center pipeline. While shareholders remain divided, with ongoing community frustration over communication delays, current discourse is heavily centered on anticipation for the upcoming quarterly earnings release and potential announcements regarding new tenant partnerships for its Helios campus.

Quantum Corp. engages in the manufacture of computer storage devices. It provides solutions for storing and protecting information in physical, virtual, and cloud environments. Its products and services include Myriad All-Flash File and Object, StorNext File System Unified Surveillance Platform, ActiveScale Object Storage, DXi Backup Appliances, Scalar Tape Storage, CatDV Media Asset Management, and Cloud-Based Analytics. The company was founded by Joel N. Harrison and James M. McCoy in 1980 and is headquartered in Centennial, CO.

Quantum Corp

Quantum Corp (QMCO) is seeing heavy volatility as traders debate whether it is a legitimate fundamental turnaround story or an algorithmic pump-and-dump scheme. The community is sharply divided, with bulls pointing to debt reduction and enterprise storage demand while bears focus on high short interest, significant share dilution, and concerns over the upcoming expiration of lock-up periods.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is currently experiencing intense market volatility driven by a high-profile short squeeze as retail bulls aggressively target short positions held by notable investors like Michael Burry. The stock's rapid appreciation has sparked polarized community debate, with bulls citing unprecedented AI infrastructure demand and potential institutional backing, while bears warn of extreme valuation concerns and significant technical overextension.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MRNA Q2 Earnings Meet, Stock Down on Norovirus Vaccine Setback

Moderna's Q2 revenue tops estimates, but shares fall after its phase III norovirus vaccine study misses early success criteria.

ABUS Stock On Track For Best Day In About Two Months — What’s The Moderna Connection?

Equity

On July 8, Arbutus received around $178 million from Moderna as part of a patent litigation settlement, the company said.


ABUS Stock Rallies Ahead Of Big Payout From Moderna Settlement This Week

Arbutus expects to receive around $179 million from Moderna. 


Moderna's Revenues See Strong International Momentum in Q1 Earnings

MRNA's Q1 revenues soar 260% on strong international vaccine sales, while cost cuts and new EU approvals support its broader growth strategy.

QuidelOrtho, MIND Technology, Southern First Bancshares And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures up, QuidelOrtho shares down in pre-market trading. Allbirds, MIND, Arbutus Biopharma among other stocks also falling.read more...

Arbutus Biopharma (NASDAQ:ABUS) Sees Large Volume Increase - Here's Why

Arbutus Biopharma (NASDAQ:ABUS) Sees Large Volume Increase - What's Next...

Arbutus Biopharma (NASDAQ:ABUS) Stock Price Crosses Above 200-Day Moving Average - What's Next?

Arbutus Biopharma (NASDAQ:ABUS) Share Price Passes Above 200 Day Moving Average - Time to Sell...

Arbutus Biopharma (NASDAQ:ABUS) Posts Earnings Results

Arbutus Biopharma (NASDAQ:ABUS - Get Free Report) posted its quarterly earnings data on Monday. The biopharmaceutical company reported ($0.01) EPS for the quarter, beating analysts' consensus estimates of ($0.06) by $0.05. The business had revenue of $1.05 million for the quarter, compared to...

Arbutus Biopharma (ABUS) Projected to Post Quarterly Earnings on Thursday

Arbutus Biopharma (NASDAQ:ABUS) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-26-arbutus-biopharma-co-stock...

Foursixthree Capital LP Has $8.99 Million Stake in Arbutus Biopharma Corporation $ABUS

Foursixthree Capital LP decreased its holdings in shares of Arbutus Biopharma Corporation (NASDAQ:ABUS - Free Report) by 22.6% during the 3rd quarter, according to the company in its most recent Form...

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Arbutus Biopharma Corp

Neutral Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a winning week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$0.02	--	--	N/A
Q2 '26	-$0.02	-$0.03	-50.00%	MISSED
Q1 '26	-$0.03	$0.87	3000.00%	BEAT
Q4 '25	-$0.04	-$0.01	71.47%	BEAT
Q3 '25	-$0.03	-$0.04	-33.33%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings